Free Alerts   Login
Health Care › Pharmaceutical Preparations

AQST Stock Price Correlated With Aquestive Therapeutics Financials

AQST Stock Price vs. Quarterly
AQST
Income Statement
Cash Flow
Balance Sheet

AQST Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

AQST Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

AQST Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Bratton Capital Management, L.P.
9,810,958 sh
 
$19,818
Armistice Capital
3,924,000 sh
2,766,000 sh
239%
$7,926
$6,015
Vanguard Group
1,889,053 sh
190,401 sh
11%
$3,816
$1,217
Renaissance Technologies
1,271,500 sh
142,311 sh
13%
$3
$1
Essex Investment Management Co
846,167 sh
846,167 sh
NEW
$1,709
$1,709
Vahanian & Associates Financial Planning.
591,608 sh
-130,500 sh
-18%
$1,195
$90
Acadian Asset Management
550,484 sh
 
$1
Geode Capital Management
494,902 sh
38,337 sh
8%
$1,000
$301
Blackrock.
478,019 sh
-1,949 sh
0%
$966
$231
Bracebridge Capital
428,571 sh
 
$866
Legato Capital Management
340,564 sh
340,564 sh
NEW
$688
$688
Marshall Wace,
288,884 sh
-21,925 sh
-7%
$584
$108
Connor, Clark & Lunn Investment Management.
261,592 sh
13,764 sh
6%
$528
$149
Latash Investments
243,134 sh
 
$491
Bridgeway Capital Management
192,856 sh
45,000 sh
30%
$390
$164
CI Private Wealth
191,626 sh
-265,700 sh
-58%
$387
-$313
Citadel Advisors
167,817 sh
166,417 sh
11887%
$339
$337
Two Sigma Investments, Lp
167,159 sh
96,078 sh
135%
$338
$229
Jane Street Group
156,085 sh
156,085 sh
NEW
$315
$315
State Street
151,537 sh
14,200 sh
10%
$306
$96

Free historical financial statements for Aquestive Therapeutics Inc. See how revenue, income, cash flow, and balance sheet financials have changed over 20 quarters since 2019. Compare with AQST stock chart to see long term trends.

Data imported from Aquestive Therapeutics Inc SEC filings. Check original filings before making any investment decision.